BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21211087)

  • 21. Comparison of drugs use according to surgical procedures as instrument for budgeting and improvement of prescription efficiency.
    Closon MC
    Acta Chir Belg; 1999 Aug; 99(4):195-200. PubMed ID: 10499395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Health care contract, economic options and budgeting in ambulatory care].
    Richter-Reichhelm M
    Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):819-25; discussion 826-7. PubMed ID: 11190917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sequlae of "silent rationing". Substantial deficits in drug management].
    MMW Fortschr Med; 2001 Jan; 143(4):43. PubMed ID: 11219284
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost containment: Europe. Germany.
    Burchardi H; Schuster HP; Zielmann S
    New Horiz; 1994 Aug; 2(3):364-74. PubMed ID: 8087598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving budget control: a case study.
    Karali J
    Hosp Cost Manag Account; 1993 May; 5(2):1-8. PubMed ID: 10125473
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hospital essential drugs in Africa. An example of pharmacoeconomic research].
    Meillon C; Stum N; Cuisinier-Raynal JC
    Dakar Med; 1996; Spec No():19-20. PubMed ID: 14520980
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rising costs of drugs in hospitals in the period 1996-2000 and over the next few years].
    Breekveldt-Postma NS; Zwart-van Rijkom JE; Egberts AC; Leufkens HG; Herings RM
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2547-51. PubMed ID: 12532669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-control and medical specialist payment: the Dutch alternative.
    Scholten GR; Roex AJ; Sindram JW
    Int J Health Plann Manage; 1998; 13(1):69-82. PubMed ID: 10178585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Challenges to achieving value in drug spending in a decentralized country: the Spanish case.
    AntoƱanzas F
    Value Health; 2003; 6 Suppl 1():S52-63. PubMed ID: 12846926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rx cost control: what's your role?
    Guglielmo WJ
    Med Econ; 2003 Feb; 80(4):27-8, 31-2. PubMed ID: 12666646
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug utilization and pharmaceutical cost-containment in germany-perspectives 1 year after enactment of the GMG].
    Schlander M
    Med Klin (Munich); 2005 Jun; 100(6):314-24. PubMed ID: 15968483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of cost and utilization of pharmaceuticals in Germany.
    von der Schulenburg JM
    Health Policy; 1997 Sep; 41 Suppl():S45-53. PubMed ID: 10174473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug cost increases are generated by the 50 top selling pharmaceuticals.
    Health Care Strateg Manage; 2001 Jun; 19(6):14-5, 1. PubMed ID: 11409091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [[Prescriptions for psychotropic drugs: results and comments on the 2007 prescription drug report].
    Fritze J
    Nervenarzt; 2008 Nov; 79(11):1337-45. PubMed ID: 19002733
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prescriptions for psychotropic drugs: results and comments on the 2005 prescription drug report].
    Fritze J
    Nervenarzt; 2006 Mar; 77(3):376-83. PubMed ID: 17078120
    [No Abstract]   [Full Text] [Related]  

  • 36. Financing structure dynamics and other determinants of Medicaid pharmaceutical expenditures, 1993-1996.
    Okunade AA
    J Health Care Finance; 1998; 25(1):59-71. PubMed ID: 9718512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Barmer reimbursement insurance pays pharmacists a fee for monitoring physicians. Pharmacists now control their prescriptions!].
    Schmidt K
    MMW Fortschr Med; 2004 May; 146(21):55-6. PubMed ID: 15373087
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinton team works with drug companies to expand access, restrict costs.
    Am J Hosp Pharm; 1993 Mar; 50(3):388, 391. PubMed ID: 8442442
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Solutions to problems in other countries].
    Wendehorst C
    Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):864-70. PubMed ID: 11190925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.